# Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo

> **NCT05950542** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Vitiligo, Generalized

## Interventions

- **DRUG:** Baricitinib

## Key facts

- **NCT ID:** NCT05950542
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-10
- **Primary completion:** 2024-09-20
- **Final completion:** 2024-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05950542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05950542, "Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05950542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*